Interdisciplinary nexgen TB research advancement center (in-trac) - texas biomed in-trac overall abstract the interdisciplinary nexgen TB research advancement center (in-trac) at texas biomedical…
Active Project Grant Awarded Last action
- Award ID
- P30AI168439
- Recipient
-
Texas Biomedical Research Institute UEI J4EYPCJDQ1H6
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $13,782,977
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date 93% complete
- Place of performance
- San Antonio, TX 78227, USA
Award details come from USAspending.gov.
Description
Interdisciplinary nexgen TB research advancement center (in-trac) - texas biomed in-trac overall abstract the interdisciplinary nexgen TB research advancement center (in-trac) at texas biomedical research institute (texas biomed) will attract the next generation of diverse researchers to the tuberculosis (TB) research field, and develop them into independent researchers with multi-disciplinary skills and real-world experience of clinical TB. The product of in-trac will be researchers that choose to work on some of the most challenging and relevant translational problems in TB, and that work across academic disciplines and within a framework of highly collaborative research. This will be achieved through 6 interrelated cores. Administrative core: the central hub of in-trac management and oversight, with responsibility for administrative and scientific leadership; coordinating communication between cores, researchers and NIH/niaid program staff and providing an organizational structure to optimize multidisciplinary collaborations and interactions between the cores and among a diverse cohort of in-trac participants. Development core: oversight of all career development programming and courses, tailoring the research and clinical experiences, both intern and externships, to each individual in-trac participant, and management of the in-trac pilot grant program. Biosafety & biocontainment core: extending the required biosafety training to a personalized curriculum including theoretical and hands-on biocontainment training, understanding the mechanical and regulatory requirements of a BSL3/ABSL3, coaching on how to develop biosafety protocols, and working through risk assessments from the perspective of a biosafety officer. Research imaging core: providing theoretical and hands-on training from single cell imaging (confocal microscopy, cytometry, live cell imaging, single cell rnaseq) through to whole body imaging in mice (ivis) and non-human primates (NHP) (pet/CT) within large, fully outfitted BSL3/ABSL3 facilities. Animal model core: implementing a training program to introduce all in-trac participants to the regulatory requirements for working with rodents and nhps, how to develop a robust experimental protocol, how to write an iacuc protocol, and hands-on animal handling and experimental procedures. Clinical research & patient care core: introducing in-trac participants to TB patient care at the only free-standing TB hospital in the US (texas center of infectious diseases) that manages some of the most challenging cases of TB nationally. Partnering with this will be a clinical research experience at the US- mexico border, to experience TB studies in under-served and under-resourced communities.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $1,149,396 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $1,149,653 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $114,988 | |
| Amendment | $114,988 | |
| Amendment | $114,988 | |
| Amendment | $1,034,911 | |
| Amendment | $1,034,911 | |
| Amendment | $1,034,911 | |
| Amendment | $1,034,911 | |
| Amendment | $1,150,146 | |
| Amendment | $1,150,146 | |
| Amendment | $1,150,146 | |
| Amendment | $1,150,146 | |
| Amendment | $1,199,368 | |
| Original award | $1,199,368 |
Show all 21
Subawards
Show all 16
Quick answers
Who received award P30AI168439?
P30AI168439 was awarded to Texas Biomedical Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 10, 2022.
How much is award P30AI168439 worth?
$13,782,977 has been obligated on P30AI168439.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award